| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Gene Therapy Program | University of Pennsylvania Catalyzing the development of transformative genetic-based therapeutics from concept to clinic. Dedicated to discovery + translational research and led by Dr. James Wilson, the Gene Therapy Program (GTP) at the University of Pennsylvania focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. Dr. Wilson's commitment to patients with rare diseases stems from his days as a graduate student and medical student at the University of Michigan between 1977 and 1984. He was discouraged by the lack of available treatments for rare disease patients, but optimistic that … Type: | 1 | 1 | 0 | 78 |
 | Scout Bio Shaping the future of veterinary medicine through one-time therapies for major chronic pet health conditions. Scout’s mission is to harness the genetic revolution transforming human medicine to deliver the future of veterinary medicine. By combining world-leading talent in animal health and gene therapy technology, we have built a development platform for one-time therapies that address major areas of unmet medical need in pet medicine. We are a global company supported by leading life sciences investors and an R&D collaboration with the renowned Gene Therapy Program at the University of Pennsylvania. About Our Currently Enrolling Study for Cats Scout’s first therapy … Type: | 1 | 1 | 0 | 16 |
 | Exothera Best-in-class viral vector and nucleic acid development and manufacturing services Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing … Type: | 0 | 0 | 0 | 165 |
 | Medical Detection Dogs Dogs Saving Lives We train dogs to help the NHS and save lives Medical Detection Dogs works with the powerful scenting ability of dogs. We train them to detect the odour of diseases like cancers, Parkinson’s disease, malaria and potentially fatal bacterial infections, as well helping people with complex, life-threatening medical conditions stay safe and lead more normal, independent lives. Our Medical Alert Assistance Dogs save lives daily by alerting their human partners to an odour change which indicates an oncoming, potentially fatal medical event. Conditions W have trained dogs to alert to include Type 1 diabetes, PoTS, Addison’s disease … Type: | 1 | 1 | 0 | 64 |
 | K9 Medical Detection New Zealand Our mission is to improve the health of all New Zealanders using specifically trained dogs in a clinical environment. K9 Medical Detection New Zealand is a registered Charitable Trust comprised of a dedicated team working to improve the health of all New Zealanders by using specially trained dogs working in a controlled clinical environment to assist in the detection of cancer and other diseases. Cancers detected at an early stage are more likely to be treated successfully. Starting the treatment while the cancer is small and confined greatly improves the survival rate. While we have sophisticated laboratory diagnostic tests for … Type: | 1 | 1 | 0 | 5 |
 | Friedrich-Loeffler-Institut [Automatic translation follows] Research for Animal Health As Federal Research Institute for Animal Health, the Friedrich-Loeffler-Institut (FLI) addresses farm animal health and welfare. The work aims at the prevention, diagnostics and control of animal diseases, the improvement of animal welfare and animal nutrition as well as the preservation and use of farm animal genetic resources. Animal health, livestock genetics, animal nutrition, animal protection, animal welfare, animal husbandry, animal epidemics, animal diseases, animal disease control, animal disease monitoring, animal disease prevention, zoonoses, animal disease diagnostics, reference laboratories, CRISPR/Cas, risk assessments, StIKo Vet, German Gene Bank, genetic resources, biobank, avian influenza/avian influenza, … Type: | 1 | 1 | 0 | 278 |
 | MabGenesis Inc. Discovery of innovative therapeutic antibodies for human and animal health MabGenesis Inc. is a biopharmaceutical company that provides fully species-specific therapeutic antibodies to human and companion animals. We have the world’s highest quality antibody libraries (MOURA Libraries) in terms of functionality and completeness, as well as highly efficient monoclonal antibody isolation technology (IMPACT). By using these, we make it possible to obtain high-affinity monoclonal antibodies that recognize unique 3D structures or subtle structural differences of target molecules such as membrane proteins, thus contributing to new drug development opportunities in the pharmaceutical industry. Biotechnology, Antibody, Monoclonal antibody, VHH, membrane protein, Canine, … Type: | 1 | 1 | 0 | 2 |
 | Cellistic Delivering the iPSC platforms that ready the world for next-gen cell therapies Launched in April 2022, Cellistic specializes in process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The company’s focus and expertise in iPSC generation and differentiation protocol development makes it well-positioned to partner with innovative cell therapy developers to establish novel advanced therapies. With more than a decade of scientific and technical knowledge transfer from sister company Ncardia, Cellistic is uniquely experienced in designing and optimizing manufacturing procedures for iPSCs that deliver quality products at scale. For more information, visit www.cellistic.com. Type: | 0 | 0 | 0 | 94 |
 |  BIOGARAN [Automatic translation follows] The box that takes care of you. French drug laboratory 🇫🇷 Biogaran was founded in 1996, to specifically respond to the development of a new, still little-known market: generic drugs. Offering patients quality drugs with recognized effectiveness whose patent had fallen into the public domain was then a new type of know-how that traditional laboratories did not possess. Our know-how is available through different ranges: from minor everyday ailments with the Biogaran Conseil® range, to more serious pathologies with prescription drugs. Whatever the pathology, patient health is at the heart of Biogaran's concerns and the same rigor … Type: | 10 | 3 | 6 | 535 |
 | Kayentis Simplify your clinical trial experience Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company … Type: | 7 | 5 | 3 | 162 |
 | Parfums Givenchy Hubert de Givenchy’s storied ascent to famed couturier began in 1952, when he opened the doors to his eponymous Parisian couture house. When Givenchy met Audrey Hepburn, he fell for her irresistible charm and youthful spirit. She informed Givenchy’s singular vision of “perfectly imperfect” beauty and inspired him to create his first fragrance, L’Interdit, made especially for her. The move into fragrances was a natural one for Givenchy, who considered his perfumes to be an extension of his couture, the elegance he wanted to give his clothes. He went on to release L’Interdit to the public in 1957 and followed … Type: | 5 | 2 | 1 | 23 |
 |  ITERG French Institute for fats & related products: fats, vegetable oils, vegetable proteins and minor compounds. ITERG contributes to the development of the fats and related products industries: fats, vegetable oils and oil co-products, vegetable proteins and minor compounds derived from these products. ITERG provides companies with production, research and expertise skills and infrastructures. It contributes to the creation of value and the competitiveness of the industrial fabric, from upstream to downstream. CENTRE D'EXPERTISE SUR LES HUILES ET MATIERES GRASSES, EXPERTISE ANALYTIQUE ET NUTRITIONNELLE, PLATEFORME DE CHIMIE VERTE, UNITE DE RAFFINAGE DES HUILES, and PLATEFORME PROTEINES VEGETALES | 24 | 10 | 13 | 74 |
 | Caduceum [Automatic translation follows] Advice for #Health industries - Partner of Lifesciences Industries. #Pharmaceutical Caduceum is a 100% health consulting company! A specialized Life Sciences subsidiary of the ALTEN group, we work with pharmaceutical, biotechnology, medical device, cosmetic and nutri-health manufacturers. It is thanks to our 400 employees that we offer a specialist approach in all phases of industrial development, from product design to marketing and post-marketing. Our expertise extends over several areas: - Engineering - Industrialization - IT & Digital - Regulatory Affairs - Quality Assurance - R&D ... and Training through its Qualiopi-certified training platform: Caduceum Academy. Basic or … Type: | 9 | 2 | 5 | 336 |
 | Laboratoires Théa Théa, Let's Open Our Eyes Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries. Ophthalmology, Pharmaceuticals, Medical Devices, Eye care, Eye Health, and Preservative-free Type: | 11 | 6 | 5 | 811 |
 | Institut Universitaire Européen de la Mer (IUEM) [Automatic translation follows] The European University Institute of the Sea (IUEM) is a multidisciplinary organization in the field of marine and coastal sciences whose activities are centered around 3 missions: research, training and observation. The IUEM brings together seven laboratories (Joint Research Units associating UBO, CNRS, IRD, Ifremer and UBS) where nearly 500 researchers, teacher-researchers, engineers, technicians and permanent and contract administrative staff work. An internal school of the University of Western Brittany (UBO), the IUEM offers within the Marine and Coastal Sciences (SML) training area, eight master's courses very closely associated with its laboratories and also houses the Doctoral … Type: | 24 | 7 | 6 | 112 |
 | OZ Biosciences OZ Biosciences creates, develops and commercializes life sciences reagents specialized in transfection and transduction OZ Biosciences is a product development company that creates, develops and commercializes delivery systems of bioactive materials (DNA, siRNA, proteins, antibodies...), intended for the worldwide scientific community and pharmaceutical industries. Our mission is to assist scientists to accelerate the rhythm of discoveries by offering them technologically advanced tools such as transfection reagents and other life science research products. Principal innovations are based on propietary technologies such as Magnetofection (magnetic-assisted transfection or infection), Magneto-Biolistic, transfection reagents, transduction tools, mRNA and lipids-based delivery systems (LNP). Specialized and expert … Type: | 3 | 1 | 2 | 18 |
 | genOway Together, we science better Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom … Type: | 5 | 3 | 1 | 109 |
 | ACAVI - Talent Acquisition Partner Management des Ressources Humaines ACAVI est une société spécialisée en Executive Search et Recrutement, Assessment spécialisé et Conseil stratégique et opérationnel dédié au Top et Middle Management des entreprises et structures académiques du secteur des Sciences de la Vie, la Chimie et les Matériaux. ACAVI est positionné en France et dans le monde comme Leader expert des métiers à forte valeur ajoutée de la Recherche, Développement, Industrialisation, Réglementaire, Qualité, Commercial, Marketing et Service. ACAVI is a company specialized in Executive Search and Recruitment, Assessment and Strategic and Operational Consulting dedicated to the Top and Middle Management for companies and academic … | 0 | 0 | 0 | 17 |
 |  AZELEAD An innovative drug discovery technology Good morning and welcome, we are pleased to introduce you to our structure. AZELEAD has developed ZebraScreen and ZebraTox, an innovative methodology for rapid and accurate assessment of the efficacy and toxicity of a drug In the past few years, we have seen a lot of attrition in the development of new drugs, with a failure rate of nearly 84% attributed to the low benefit of efficacy / toxicity. Three therapeutic areas are mainly affected by this decrease: oncology (failure rate of 29.5%), neurology (failure rate of 14%), and infectious diseases (failure … Type: | 0 | 0 | 0 | 3 |
 | Filière Intelligence Artificielle & Cancers [Automatic translation follows] Transforming data into tangible innovations. The "Filière Intelligence Artificielle & Cancers" Association was created on August 3, 2021. It is the result of an unprecedented public-private partnership and brings together representatives from the National Cancer Institute, the Health Data Hub, the Alliance for Research and Innovation in Health Industries, France Biotech and nine of the world's largest healthcare manufacturers in oncology: Amgen, AstraZeneca, Bristol-Myers Squibb, Janssen, MSD, Novartis, Pfizer, Pierre Fabre and Roche diagnostic. Its ambition is to address, through all the data available in France, questions that bring value to patients and are transformed into tangible … Type: | 9 | 3 | 7 | 8 |
 | Physics for Medicine Paris Inserm, ESPCI Paris-PSL, CNRS - Invent the future of biomedical technologies Physics for Medicine Paris is a French academic research institute dedicated to develop non-invasive technologies for medical imaging and therapy based on innovative concepts of wave physics. Type: | 4 | 2 | 2 | 23 |
 | ScienceOne AI-Powered Professional Platform for Life Sciences AI-Powered Professional Platform for Life Sciences Promote and interconnect talented people and organization with Life Sciences ScienceOne is a dynamic and innovative organization that is at the forefront of scientific research and development. Our mission is to drive breakthroughs in technology, medicine, and engineering through collaboration and knowledge sharing. As ScienceLeadR.eu, we aim to connect scientists, researchers, and industry leaders to foster collaborations and accelerate the pace of scientific discovery. Join us to be part of a community that is shaping the future of science. santé, Health, biotech, healthtech, medtech, drugs, healthcare, health experts, … Type: | 16 | 2 | 16 | 7 |
 | FenoMark Diagnostics AB Dedicated to the discovery and development of biomarkers lung cancer patients Dedicated to improving cancer care by developing better diagnostic assays for therapy selection. diagnostics, cancer, proteomics, lung cancer, and biomarkers | 1 | 0 | 0 | 2 |
 | Epigenica Bringing the first multiplex, high-throughput tools to epigenomic research Epigenica is a life sciences technology company at the forefront of innovations in epigenetic research. The company’s EpiFinder platform enables researchers to perform comprehensive epigenetic studies at unprecedented speed, scalability, and affordability. Epigenica is building a portfolio of products based on the EpiFinder platform to offer comprehensive high-throughput profiling at different depths of detail with an array of possible starting materials. The platform is powered by the company’s patented and proprietary high-throughput, multiplex, quantitative ChIP-seq technology (hmqChIP), the first commercial kit of its kind. With the advantages of the EpiFinder platform, … Type: | 6 | 0 | 1 | 13 |
 | Weleda France [Automatic translation follows] #Focus_GrowthThatMatters * * Growth that makes sense Nature is our source of inspiration. Faithful to this fundamental principle since 1921, we offer products exclusively derived from nature: homeopathic and phytotherapeutic medicines as well as cosmetic care. All our energy and know-how are mobilized to develop biodiversity, care for the soil, preserve the vitality of plants, draw with respect from the diversity of nature and transmit its healing virtues to human beings. | 5 | 2 | 2 | 144 |
 | SingCell A stem cells Contract Development and Manufacturing Organisation (CDMO) in Singapore. MSC, iPSC, clean meat. SingCell offers process development and contract manufacturing services for stem cell therapy and clean meat companies. SingCell leverages its proprietary technology to improve manufacturing processes and offer high consistent quality stem cells. #cleanmeat #celltherapy Type: | 0 | 0 | 0 | 1 |
 | CollPlant Pioneering Regenerative Medicine CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, we are developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics. Our mission at CollPlant is to deliver ground-breaking … Type: | 1 | 0 | 0 | 72 |
 | INFORS HT Incubation shakers, bioreactors and bioprocess software for reliable and efficient cultivations. INFORS HT is your specialist for bioreactors, incubation shakers and bioprocess control software for reliable and efficient cultivations. You benefit from sophisticated systems, in which your cell lines or microorganisms develop their full potential in a reproducible way, thus contributing to your success. For your applications, we offer the right solutions: Fermentation of microorganisms (bacteria, fungi and yeasts) Cell culture (mammalian cells, insect cells, plant cells and algae) Biofuel (biodiesel and bioethanol) Parallel bioprocesses Custom-made bioreactors and incubation shakers Bioprocess control software Qualification of bioreactors and incubation shakers Closeness … Type: | 1 | 0 | 1 | 170 |
 | The Breast Cancer Research Foundation The highest-rated breast cancer org in the U.S. We fund research to find a cure in our lifetime. BCRF is the highest-rated breast cancer organization in the U.S. We provide critical funding for cancer research worldwide to fuel advances in tumor biology, genetics, prevention, treatment, metastasis and survivorship. Since our founding in 1993 by Evelyn H. Lauder, BCRF has raised more than half a billion dollars for lifesaving research. Through a unique and streamlined grants program, we seek out the brightest minds in science and medicine and give them the necessary resources to pursue their best ideas. As a result, … | 10 | 4 | 11 | 90 |
 | Fraunhofer ISST #InnovationsFromData #dataspaces #industrialmanufacturing #healthcare #smartcities #itserviceproviders The »Fraunhofer-Institut für Software- und Systemtechnik ISST« (Fraunhofer Institute for Software and Systems Engineering) develops data space technologies for sovereign data exchange and builds pioneering data ecosystems with its partners. The institute is located in Dortmund / Germany. It is part of the »Fraunhofer-Gesellschaft e.V.« the biggest corporation for applied research in Europe. Together with companies, the Fraunhofer Institute for Software and Systems Engineering ISST identifies the strategic value of their data and makes it usable - from data preparation to the development of new business models, the institute offers complete system solutions. In … Type: | 23 | 5 | 15 | 149 |
 | NeuroClin Ltd NeuroClin Glasgow - pioneering neuro clinical research in Alzheimer’s, Dementia, Parkinson's and Depression. NeuroClin Glasgow is an independent research organisation dedicated to pioneering new research and treatments for Memory Impairment, Alzheimer's, Dementia, Parkinson's, Depression and other neurological conditions. We aim to help and support those who have a wide range of memory difficulties and to ensure the highest standards of care and attention for those participating in our research programmes. We are the only centre in Scotland which has conducted research on all of the currently licensed treatments for Alzheimer’s disease. Research and Clinical Trials Type: | 0 | 0 | 0 | 41 |
 | Signant Health The Evidence Generation Company Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics. Learn more at www.signanthealth.com. clinical trial software, eCOA, eConsent, IRT, Clinical Supply Optimization, Patient Engagement, Rater Training, Data … Type: | 12 | 2 | 8 | 2,077 |
 | RELIEF THERAPEUTICS Holding SA Providing relief to patients with unmet medical needs in select specialty and rare diseases. RELIEF THERAPEUTICS Holding SA (SIX: RLF; OTCQB: RLFTF, RLFTY) We are a biopharmaceutical company committed to providing therapeutic relief to patients living with rare diseases. Our goal is to advance treatment paradigms and deliver improvements in efficacy, safety and convenience to benefit the lives of patients and their families. Our therapeutic focus is on rare indications for metabolic disorders, pulmonary diseases, and dermatology/connective tissue disorders. Acute Lung Injury, Pulmonary Sarcoidosis, Lung Fibrosis, Acute Respiratory Distress Syndrome, Urea Cycle Disorders, Maple Syrup Urine Disease, Rare Diseases, Epidermolysis … Type: | 0 | 0 | 0 | 10 |
 | Fundación Recal [Automatic translation follows] An open door to recovery. The Recal Foundation is a centre specialising in the treatment of alcoholism, addiction to all drugs, but also to behaviours such as gambling, internet, shopping, food (bulimia, binge eating, food cravings and/or compulsive eating) or sex. Effective interventions are also offered for the treatment of smoking. We have a team of: Psychiatrists, Doctors, Nurses, Psychologists and Therapists. Addiction treatment Type: | 1 | 1 | 0 | 27 |
 | EveryLife Foundation for Rare Diseases The EveryLife Foundation for Rare Diseases educates, supports and amplifies the voice of rare disease patient advocates. We empower the rare disease patient community to advocate for impactful, science-driven legislation and policy that advances the equitable development of and access to lifesaving diagnoses, treatments, and cures. Advocacy, Patient Engagment, Rare Diseases, and Public Policy Type: | 15 | 0 | 14 | 61 |
 | GENFIT Dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs. GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from early-stages to late development and pre-commercialization stages, is illustrated through the successful 52-week readout of its Phase 3 trial (ELATIVE®) evaluating elafibranor in Primary Biliary Cholangitis (PBC). Today, … Type: | 10 | 5 | 5 | 190 |
 | Vect-Horus Enhancing the transport of therapeutic and imaging agents using versatile and flexible targeting technologies VECT-HORUS, Breaking barriers Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain and tumours. Vect-Horus combines these different agents to its vectors that specifically target various receptors, allowing these agents to cross natural barriers (first and foremost the blood-brain-barrier) which limit access of therapeutic or imaging agents to their targets. The proof of concept of the technology has already been established in animal models using different vectorized molecules. Vect-Horus endorces a mixed business model, based … Type: | 24 | 6 | 10 | 46 |
 | DIM ELICIT Empowering LIfe sCiences with Innovative Technologies The DIM ELICIT is the network of innovative technologies for biology in Ile-de-France region. Co-leaded by the Institut Pierre Gilles de Gennes for microfluidics (IPGG) and the Institut Pasteur, the DIM ELICIT has been labeled "Domain Of Main Interest" by the regional council of Ile-de-France for the period 2017-2020. Through calls for proposals, this programme supports Paris region research teams to design breakthrough technologies or to disseminate them for first applications in biology. It stimulates interdisciplinary collaborations between technologists and biologists, as well as partnerships with industries. These technological innovations must have a strong … Type: | 8 | 0 | 8 | 1 |
 | SIRIC BRIO - Bordeaux Recherche Intégrée en Oncologie [Automatic translation follows] Translational research on geriatric oncology, sarcomas and tumor microenvironment + focus on patient involvement (PPI) The SIRIC BRIO aims to offer new operational conditions to cancer research, with the aim of optimizing and accelerating the production of new knowledge and promoting its dissemination and application in cancer care. BRIO's integrated research projects aim to bring together and organize in an integrated manner on a single site, fundamental, clinical, human and social sciences, epidemiology and public health research with the ultimate goal of transferring it to patients, in the form of diagnostic tests, drugs, social or public health … Type: | 4 | 0 | 3 | 1 |
 | ATLANCHIM PHARMA BUILDING MOLECULES FROM IDEAS ATLANCHIM PHARMA is a chemistry-based CRO (Contract Research Organization) conducting confidential custom synthesis of complex molecules tailored to customer specifications. Our team provides multi-step organic synthesis from a milligram to several gram scale. CRO, Custom synthesis, Chemistry, Research & Development, Organic chemistry, Medicinal chemistry, Reproduction services, Stable isotope labeling, Organic synthesis, Heterocycle synthesis, Carbohydrate chemistry, Peptide synthesis, Impurety synthesis, and Hit to lead Type: | 3 | 1 | 3 | 12 |
 | GTP Bioways Customer-centric and science-driven CDMO supporting biopharma companies from R&D to market GTP Bioways is an expert and fast-growing contract development and manufacturing organisation (CDMO) offering uniquely customised process development and manufacturing services for biologics, antibody-drug conjugates and nanodrugs. With cutting-edge facilities located in France, GTP Bioways supports biopharma companies in bringing their innovative molecules from research to clinic and market. Biologics, Nanodrugs, Process Development, Analytics, Biopharmaceuticals, and GMP Manufacturing Type: | 21 | 5 | 20 | 149 |
 | La Roche-Posay Laboratoire Dermatologique LIFE-CHANGING SKINCARE PRESCRIBED BY DERMATOLOGISTS At La Roche-Posay, we know skin is a matter of life. While skin issues can scar our lives in more ways than one, healing skin has the power to change lives in more ways than one. Everyday, we drive dermatology forward by joining forces with the medical community. Together, we pioneer new ways to be at the service of people. By bringing together radical efficacy and profound human understanding. By revealing the life impact of skin issues, one study at a time, to broaden the scope of care. By bringing the most advanced dermatological knowledge … | 1 | 1 | 0 | 314 |
 | Science 37 Access More Patients. Enroll Faster. Science 37’s mission is to accelerate clinical research by enabling universal trial access for patients. Through our solutions; the MetasiteTM and Patient Recruitment, we accelerate enrollment by expanding the reach of clinical trials to patients beyond the traditional site and rigorously qualifying patients prior to referring them to a traditional site. Our solutions are powered by a proprietary technology stack with in-house medical and operational experts that enhance quality through standardized workflows and best-in-class study orchestration. Patient Recruitment, Patient Qualification, Clinical Trial Enrollment, Clinical Trial Access, Site Conduct, Virtual Site, Hybrid Clinical Trials, Remote Clinical … Type: | 5 | 0 | 4 | 331 |
 | Boundless Bio Unbound by convention, bound to save lives Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence. When DNA in cancer cells comes off chromosomes, “extrachromosomal DNA (ecDNA),” it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes, driving cancer cells to grow and allowing them to resist treatment. At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells’ ability to employ ecDNA to survive. Our Culture: At Boundless, you’ll … Type: | 3 | 0 | 1 | 83 |
 | Mitsubishi Tanabe Pharma America We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, … Type: | 5 | 0 | 2 | 263 |
 | ImmunXperts, a Q2 Solutions Company Your partner in immunology projects! ImmunXperts a Q2 Solutions Company, your partner for what’s next in assay and biomarker development, advanced laboratory testing, and translational immunology. ImmunXperts brings an unrivaled ability to efficiently develop immunogenicity and immuno-oncology in vitro assays – to address both wanted and unwanted immunity for novel modalities. Immunogenicity Assessment, Immune Academy, Training, Consultancy, immuno-oncology, Cell Therapy, In vitro, assay development, Primary cells, Immunogenicity, and Immunology Type: | 1 | 0 | 0 | 24 |
 | TG Therapeutics, Inc. TG is a biopharmaceutical company focused on the development of novel treatments for B-cell diseases. TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS). Biotechnology, hematological malignancies, non-Hodgkin's lymphoma, multiple sclerosis, b-cell diseases, ublituximab, and umbralisib Type: | 0 | 0 | 0 | 384 |
 | Replimune Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel oncolytic immunotherapies. We imagine a world where cancer is a curable disease. | 2 | 0 | 1 | 342 |
 | 3Brain AG We empower researchers to explore intelligent biological networks by linking them to information technology. 3Brain developed and distributes the world’s first commercial CMOS-based high-resolution Microelectrode Array (MEA), a Biosensor integrating thousands of tiny electrical sensors in a small area. Our Biosensor allows non-invasive (in vitro) investigations of electrogenic cells, such as neurons, cardiac and muscle cells. The technology can be used to investigate electroactive cells' fundamental properties (e.g., neural code for learning and memory), to study and find new treatments to different types of diseases (e.g. Alzheimer and epilepsy) and to assess compounds/chemical toxicity. Microelectrode Arrays, High Resolution Electrophysiology, Electrophysiology … Type: | 1 | 0 | 1 | 54 |
 | Nagi Bioscience in vivo testing at the in vitro scale Nagi Bioscience is a pioneering high-tech startup developing NextGen laboratory equipment to unlock the full potential of alternatives to animal testing. Located in the heart of the Swiss "Health Valley”, we work for the transformation of biological testing standards providing cutting-edge equipment to achieve faster, scalable, more efficient and ethical methods. Under the motto “in vivo testing at the in vitro scale”, our technologies are accelerating drug development pipelines and introducing new toxicology testing standards revolutionizing pharmaceutical, cosmetic, and agro-chemical industries among others. Our approach? To unlock the full potential of small … Type: | 3 | 2 | 2 | 29 |
 | AgroSustain SA AgroSustain – a one-stop-shop solution for biological plant protection. AgroSustain – a one-stop-shop solution for biological plant protection. We aim to reduce food waste and support organic food production by developing farm to fork solutions, like biological fungicides and coatings. AgroSustain has developed a pipeline of plant-derived antifungal compounds against broad range of agronomically important fungal pathogens present in pre- (in the field) and post-harvest (in storage). AgroSustain’s first product, called AgroShelf+, extends shelf life of vegetables & fruits infected with mostly spread molds. AgroSustain’s B2B customers, food distributors & producers with post-harvest storage facilities, that value more the effectiveness … Type: | 10 | 5 | 2 | 10 |
 | TRON-Mainz Science in Translation - We put inspiration into practice, finding viable solutions to complex challenges. Our mission is to turn scientific breakthroughs into progress for patients. TRON is a non-profit research institute that pursues new diagnostics and drugs for the treatment of cancer and other diseases with a high medical need. We aim to bridge the gap between fundamental science at universities and market-oriented research in the pharmaceutical industry. We turn innovative scientific concepts into treatments ready for clinical testing, thereby accelerating the translation of discoveries into new diagnostics and therapies for patients. We focus our transdisciplinary competencies in genomics … Type: | 2 | 0 | 2 | 165 |
 | Iconthin Biotech The full-service specialist for algae-based health products. Home of AstaDaily®, AstaDermal®, AlgaeAstaTM and AlgaeO3. Iconthin Biotech, a specialist in Algae-Based Ingredients, is dedicated to pioneering sustainable biotechnology. Our focus extends from enterprise services to the development of consumer-facing products, including nutraceuticals, skincare, and functional foods. At the core of our cutting-edge technology is our commitment to innovation, underscored by our partnership with the renowned microalgae research team at the University of Toronto. We proudly introduce AlgaeAstaTM - Leading with Natural Astaxanthin. Discover the power of AlgaeAstaTM Astaxanthin, derived 100% from the microalgae Haematococcus pluvialis using the latest 3rd generation cultivation … Type: | 11 | 0 | 11 | 6 |
 | Sonata Therapeutics Sonata Therapeutics is a new, Boston-based Flagship Pioneering company revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. Our product-platform creates drugs based on a systematic, comprehensive characterization of the microenvironment in diseases with high unmet medical need. Through our pioneering science, we identify new targets for therapeutics that induce the release of a programmed diversity of signals with the potential for significant patient impact. Our employees are exceptionally passionate, accountable, collaborative, and innovative. Sonata Therapeutics was founded by Flagship Pioneering, an organization dedicated to the origination and development of first-in-category life sciences … Type: | 7 | 0 | 7 | 44 |
 | Intravacc Innovating vaccines to reduce human diseases. Part of Utrecht Science Park Bilthoven Even the most promising vaccines don’t always make it out of the laboratory into large-scale production. We at Intravacc are fully aware of the challenges on the long road of vaccine development. We substantially reduce the risks and costs involved with developing vaccines. How? By bridging the gap between your concept and late stage clinical studies. As an established independent CDMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials … Type: | 2 | 0 | 0 | 63 |
 | Arvinas Leading the way in targeted protein degradation therapeutics Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting estrogen receptor for patients with locally advanced or … Type: | 4 | 0 | 2 | 444 |
 | Kymab Ltd Kymab, a Sanofi company, based in Cambridge UK, is working to provide novel solutions in drug and vaccine development. Kymab, a Sanofi company, is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available. Kymab’s platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with … Type: | 4 | 1 | 0 | 39 |
 | UNIVERCELLS For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designed and produced. At Univercells, we believe in the power of small adaptations to drive big change. We embrace the spirit of evolution in everything we do. We are biotech innovators. We are scientists and entrepreneurs creating transformative platforms for the pharmaceutical and biotech industry, through technology, bioprocess know-how and entrepreneurial spirit. Biotechnology, mRNA, CDMO, and Services Type: | 4 | 1 | 3 | 176 |
 | Airfinity Ltd The disease forecasting company, helping you track, predict, and simulate to achieve better disease outcomes. Airfinity tracks, simulates, and predicts population level disease outcomes in real time to inform decisions that can increase the global life span. Specialising in infectious diseases, Airfinity works with the entire life science ecosystem. Our suite of proprietary surveillance tools and forecast models analyse and predict disease outcomes. Spanning over 150 viral, bacterial and fungal pathogens, we use advanced meta science, statistics, epidemiology and machine learning solutions to dynamically understand true disease prevalence and underlying outcome drivers. By combining this with expert analysis and commentary … Type: | 18 | 0 | 18 | 98 |
 | IgniteData Shaping the Future of Clinical Trial Data IgniteData’s Archer technology is transforming the way hospitals and research sites transfer data for clinical trials. EHR-to-EDC data transfer provides fast, accurate patient data for clinical studies, significantly reducing the requirement for laborious data transcription and source data verification (SDV). pharmaceutical, NHS, Electronic Health Records, healthcare data, Clinical Research, Clinical Trials, Clinical Studies, Site Data Verification, biopharma, biopharmaceutical, EHR, EMR, EHR2EDC, interoperability, DigiHealth, medtech, software, life science, healthcare, eClinical, and TrialTech Type: | 5 | 0 | 4 | 19 |
 | ReCode Therapeutics Powering the next wave of genetic medicines through superior delivery ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. RNA Therapies, Genetic Medicines, Non-Viral Lipid Nanoparticles, Genetic Respiratory Disease, Cystic Fibrosis, Primary Ciliary Dyskinesia, and Biotechnology Type: | 4 | 1 | 4 | 120 |
 | BioCentriq Manufacturing Partner for Cell Therapy Process Development and Clinical Production BioCentriq is an established, highly collaborative, global cell therapy CDMO. The company has been successfully manufacturing drug products for use in human clinical trials since 2022. In June of 2023, BioCentriq launched its LEAPTM Advanced Therapy Platform which helps cell therapy developers move from contract to clinic in as short as six months. With industry recognized scientists, engineers, analysts, and manufacturing specialists, established quality systems and modern infrastructure, BioCentriq is a proven strategic partner for the development and manufacturing of both autologous and allogeneic cell therapy products. The company was … Type: | 2 | 0 | 1 | 58 |
 | Century Therapeutics, Inc Harnessing the power of adult stem cells to develop curative therapies for cancer and autoimmune diseases Our genetically engineered, iPSC-derived cell products are designed to specifically target hematologic and solid tumor cancers, with a broadening application to autoimmune diseases. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of … Type: | 2 | 0 | 0 | 182 |
 |  Gyroscope Therapeutics Vision for Life: Developing gene therapies and delivery technologies for eye diseases. About Gyroscope Therapeutics, a Novartis company: Gyroscope Therapeutics is a clinical-stage gene therapy company developing gene therapy beyond rare disease to treat diseases of the eye that cause vision loss and blindness. The company was acquired by Novartis, a leading global medicines company, in February 2022. Gyroscope’s lead investigational gene therapy, GT005, is currently being evaluated in Phase II clinical trials for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness. GT005 has received Fast Track designation from the U.S. … Type: | 1 | 1 | 0 | 49 |
 | ZEOFORM Zeoform Micro PulpTM is the world's most sustainable material, made from the world's most renewable resource. Zeoform Micro Pulp uses the world's most renewable resource to make the world's most sustainable material. Whether you want to grow your business, refresh your supply chain, enter a new market or de-risk your product portfolio. Take your business from where you are now to where you want to be. Type: | 2 | 1 | 1 | 8 |
 | Velocity Clinical Research, Inc. Delivering high-quality clinical trial data and patient care with unprecedented efficiency. Velocity is the world’s leading organization of fully integrated clinical research sites. With 90 sites and more than 220 investigators, Velocity partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, diagnostics, and combination products that could improve human health and wellbeing. Velocity offers unified research site solutions to efficiently provide the right patients, investigators, and research staff for clinical trials across the U.S. and Europe. The company also operates a technology hub in India, where it is unlocking a new era in clinical research by developing … Type: | 6 | 0 | 6 | 1,011 |
 | OxSonics Therapeutics Tackling the toughest cancers. We’re OxSonics, a pioneering clinical-stage therapeutics company committed to developing a ground-breaking platform technology to make anti-cancer drugs smarter, act faster and, above all, work better. Our SonoTran® Platform has been designed to actively enhance the delivery of oncology drugs into solid tumours. SonoTran® is drug agnostic and requires no drug reformulation enabling its use with both existing and novel therapies. We have our own development programs as well as collaborations with Pharmaceutical and biotech companies to work to bring smarter, faster and better therapies to as many patient groups as possible. Drug Delivery, Oncology, Medical … Type: | 1 | 0 | 0 | 18 |
 | Oxford Cancer Biomarkers Pioneering Precision Medicine Oxford Cancer Biomarkers translates ground-breaking scientific discovery into predictive biomarker diagnostic products that allow medicines to be personalised for the benefit of the cancer patient. Oxford Cancer Biomarkers is a spin-out of the University of Oxford and has strong links with the Medical Sciences Division in Oxford University. The company was founded by Nick La Thangue, Ph.D., Chair of Cancer Biology at Oxford University and David Kerr, CBE, D.Sc., M.D. FMedSci, Professor of Cancer Medicine at Oxford University. Investors in OCB include Longwall Venture Partners LLP, Esperante BV, Ningbo My-BioMed Biotechnology Co.,Ltd., CancerRop Co. Ltd., and the … | 2 | 0 | 0 | 8 |
 | Kyowa Kirin, Inc.- U.S. Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives. Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes offices in Princeton, NJ; Toronto, Canada and a research facility in La Jolla, CA. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. Our growth … Type: | 3 | 0 | 3 | 683 |
 | Albireo Pharma, Inc. On March 2, 2023, Albireo was acquired by Ipsen, strengthening Ipsen’s rare disease portfolio with promising therapeutics for pediatric and adult rare liver diseases. Albireo Pharma is a rare disease company focused on the development of novel bile acid modulators to treat pediatric and adult liver diseases. Albireo’s lead product, Bylvay, was approved by the U.S. FDA as the first drug for the treatment of pruritus in all types of progressive familial intrahepatic cholestasis (PFIC), and in Europe for the treatment of PFIC. Bylvay is also being developed to treat other rare pediatric cholestatic liver diseases with a completed Phase … Type: | 2 | 2 | 1 | 106 |
 | Adan Medical Innovation Improving anaphylaxis management Adan Medical Innovation is a company focused on the improvement of the quality of life of patients that suffer from anaphylaxis, a severe allergic reaction. To achieve this, we have formed a group of experts in different fields (physicians specialized in Allergy and Internal Medicine, business development, patent and regulatory health technologies issues, engineers, information technologies), even including patients among us, and we are working together to offer the best solutions for these patients. The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays two different products in its pipeline: AnAPPhylaxis, a … Type: | 9 | 2 | 5 | 5 |
 | TriSalus Life Sciences An immunotherapy company working to improve the lives of patients living with liver and pancreatic tumors TriSalus Life Sciences is an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors. Type: | 0 | 0 | 0 | 116 |
 | OMass Therapeutics OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona Ltd and Oxford Science Enterprises. Type: | 13 | 3 | 5 | 80 |
 | Shorla Oncology At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. At Shorla Oncology we develop and commercialize innovative oncology drugs. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments. Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical … Type: | 8 | 2 | 5 | 33 |
 | SiriusXT Whole-Cell Nano-Tomography SiriusXT has developed and manufactures a soft x-ray microscope (the SXT system), which is marketed primarily to researchers working in disease research and drug discovery. The core technology, underpinning the SiriusXT microscope is a vacuum-based laser-produced plasma (LPP) soft x-ray light source. Soft x-ray tomography is essentially a CT scan of the cell, and is critical to life scientists looking to image the 3D internal structure of an entire cell in its native fully hydrated state. The SXT system is used by disease researchers, pharmaceutical companies, bio-technologists and clinicians to aid the understanding of disease pathways, protein-drug interactions … Type: | 0 | 0 | 0 | 27 |
 | Ostoform The New Standard. Ostoform addresses ostomy challenges with its groundbreaking FLOWASSIST technology, redirecting output to minimize leaks, enhancing skin health, and reducing care costs. Born from a commitment to improve life for ostomates, Ostoform is dedicated to setting a new standard in stoma care through empowering breakthrough solutions. Ostomy, Stoma Care, Ostomy Appliances, Manufacturer, Medical Device Manufacturer, Medical Device, Ostomy Barrier Ring, Ostomy Seal, Ostomy Pouches, and Ostomy Care Type: | 1 | 1 | 0 | 20 |
 | Daré Bioscience, Inc. Daring to be different Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. With eight potentially first-in-class women’s health products in development, we are committed to bring to market differentiated products designed to expand treatment options, improve outcomes, and facilitate a better quality of life for women. Vaginal drug delivery is often the optimum delivery approach to achieve these objectives, and IVR technology has become one of our preferred investigational platforms. Our portfolio features innovative IVR technologies including our non-hormonal contraceptive Ovaprene®, which we believe has the potential to disrupt … Type: | 6 | 0 | 5 | 26 |
 | AOA Dx Revolutionizing early diagnosis of Ovarian Cancer AOA Dx is developing the next frontier in early-stage cancer detection for women through its pioneering work in glycolipids and proprietary biomarker technology. Our revolutionary tumor marker ganglioside platform, GlycoLocateTM, is paving the way for life-saving early cancer detection. In a first of its kind, AOA Dx is developing AKRIVIS GDTM, an early-stage liquid biopsy test for ovarian cancer, that has proven excellent sensitivity and specificity in a recent study. We foresee novel tumor biomarker gangliosides as the future for diagnosis, prognosis, monitoring, and eventually targeted therapies across multiple cancers. AOA Dx was co-founded … Type: | 5 | 0 | 5 | 37 |
 | BioMin Technologies Limited A patented bioactive material for treating dentine hypersensitivity and providing additonal protection from tooth decay. BioMin Technologies Ltd was established in 2014 to commercialize research from Queen Mary University London and Imperial College, London. We specialise in the development of bioactive glass materials for treating dentine hypersensitivity and providing additonal protection from tooth decay. BioMin’s technology is based on three core patent applications that enable the slow release of Fluoride, Calcium and Phosphate ions that enable the formation of Fluorapatite and as such outperform equivalent products on the market. This has numerous dental applications, from toothpaste and composites, to orthodontic … Type: | 1 | 1 | 0 | 12 |
 | Onalabs Inno-Hub The future of biomonitoring Point-of-Care (POC) technologies, designed to provide rapid clinical diagnosis at, or near the site of patient care, has the potential to sense changes in well-known biomarkers used already to monitor patients with chronic cardiac and respiratory diseases. However, they need to be measured in blood, which limit their use only in medical institutions. Our non-invasive products based on wearable formats will empower the patients and their families to measure relevant biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier (self-)management strategies, resulting in shorter … Type: | 9 | 2 | 7 | 22 |
 | BDI biotech BDI biotech provides biotechnological services and solutions in the Cosmetics, Agro, Food and Industrial fields. At BDI biotech we provide biotechnological services and solutions in the Cosmetics, Agro, Food and Industrial fields to bring ideas from bench to reality. We works as an external R&D department specialized in strain and bioprocess development (production, recovery and/or its application), scale-up and regular batches productions. Our Services: 1) Strain Selection & Improvement. Whether it's yeast, fungi, or bacteria, we provide the tools and services to increase byproduct or biomass production. 2) BioProcess Development & Scale-Up: BDI biotech has strong expertise in bioprocesses optimization, … | 1 | 0 | 1 | 46 |
 | HiberGene Diagnostics Saving Time, Saving Life. HiberGene Diagnostics is a Dublin-based, private Irish company, that develops, manufactures and markets molecular diagnostic tests for the direct detection of human infectious diseases, using the LAMP (Loop Mediated Isothermal Amplification) technology. In May 2020, HiberGene successfully completed the CE marking of a new fast molecular COVID-19 test. The new COVID-19 test, which expands the company’s product range to 13 tests. Positive results are returned within a few hours, enabling rapid diagnosis of the disease at the early and highly infectious stage of infection. With its expanding HG product line, HiberGene is committed to providing rapid … Type: | 2 | 0 | 2 | 8 |
 | KetoSwiss AG Fuel for brains. KetoSwiss is a Swiss biotechnology company located in Basel, that develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolic dysfunction (such as Alzheimer's disease). The lead product’s active substance is an endogenous metabolite – a Ketone body, that can be used by the human brain as an alternative source of fuel to glucose, when glucose utilization or transport is compromised. Migraine, Alzheimer's, Neuroscience, Medical Food, Biotechnology, Mental Health, Ketones, Supplements, and Novel Food Type: | 1 | 0 | 1 | 8 |
 | Perfect Day Complete whey protein, made more sustainably. We’re rethinking everything. Starting with food. Using safe, proven fermentation methods we make animal-free whey protein from microflora – not cows – to make dairy that’s identical to traditional milk. The production of our whey protein emits up to 97% less greenhouse gas emissions, uses up to 99% less blue water, and uses up to 60% less nonrenewable energy, compared to the production of protein found in traditional milk. Our protein comes in a variety of applications including cream cheese, barista milk, ice cream, protein powder, egg replacer, bakery mix, confectionery, and gelato. Some … Type: | 25 | 5 | 21 | 302 |
 | Bitbrain High-tech EEG brain sensing devices & software solutions for human behaviour research, health and neurotech development. Bitbrain was founded in 2010 as a spin-off company of a research team from the University of Zaragoza, pioneer in approaching brain-computer interface applications outside laboratory investigation settings. Its DNA holds all knowledge in neurotechnology, biomedical engineering, artificial intelligence and data science accumulated at the university since 1998. Nowadays, the R+D+I bet is still strong, which has converted the company in a world reference for B2B neurotechnology solutions. Neurotecnología, Investigación y Desarrollo, Decodificaciones complejas de señales fisiológicas, and Neuromarketing Type: | 14 | 1 | 10 | 62 |
 | Artus Therapeutics Sealing The Broken Barrier Currently we are not hiring. Please beware of scammers Artus is a pre-clinical stage company developing first-in-class therapeutics for inflammatory and metabolic diseases by targeting barrier dysfunction. Type: | 1 | 1 | 0 | 3 |
 | Provention Bio, a Sanofi Company Provention Bio is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated diseases. At Provention Bio, we approach autoimmune disease differently than traditional pharma, with a clear focus on early interception. Before symptoms present, before irreversible damage is done to the bodies, minds, and lives of patients and families, and before it’s too late —this is where we operate. Our lead investigational product candidate is currently under review by the U.S. Food and Drug Administration (FDA) for the delay or prevention of clinical type 1 diabetes in at-risk individuals. … Type: | 1 | 1 | 1 | 76 |
 | GENZ Biotechnology Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik … Type: | 0 | 0 | 0 | 3 |
 | Molecular Attraction AB New Way of VECTOR CONTROL Molecular Attraction technology enable development of vector-diseases control and eradication strategies. We are a bio-attractant discovery company. We identify biological compounds which can change behaviour of vectors organisms like mosquitoes, flies or rodents. Molecular Attraction compounds includes: Volatile attractants Phagostimulants Pheromones Molecular Attraction is a biotechnology company anchored in high-end research stemming from Stockholm University. Our competence: Biochemical compound identification Insect behaviour Parasitic infections biochemistry and immunology vector control, malaria, dengue, mosquitoes, vector diseases, pest control, and sustainability | 3 | 0 | 3 | 13 |
 | Oxurion NV Advancing Science. Enhancing Vision Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel therapeutic for the treatment of DME. THR-149 is a potent plasma kallikrein inhibitor being developed as a potential new standard of care for the up to … Type: | 0 | 0 | 0 | 34 |
 | Alvotech Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory Type: | 0 | 0 | 0 | 878 |
 | Nanovation Partners, LLC Starting in the mid 1990’s, the founders of Nanovation Partners LLC sponsored research at the University of California at San Diego (UCSD) in the lab of Sungho Jin, PhD. This research showed enhanced osseointegration and reduced implant surface infection by forming thousands of rows of tiny metal oxide nanotubes per square millimeter on the medical implant-to-tissue surface. These nanotubes were formed into the metal oxide surface already present on metal implants. No new materials were formed and no synthetic hydroxyapatite or other coating was needed. The group noticed that nearby stem cells treated the nanotube surfaces more like the outer … Type: | 0 | 0 | 0 | 2 |
 | REGEnLIFE Neurotech & photomedicine REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia. MedTech, NeuroTech, Neurophonic, Photonics, … Type: | 21 | 3 | 12 | 12 |
 | MT-act FROM DISCOVERY TO THERAPEUTICS MT-act is a CNRS spin-off. #techtransfer We develop class compounds to treat human pathologies that share a common molecular defect; dysfunction of the skeleton of the cells called microtubules - abbreviated MT. Stiffening of the skeleton of our cells is a central disease driver. That is why we act on them. We developed a technology platform to charter an entirely neglected pharmaceutical space. MT-act prioritizes indications based on scientific evidence, proven unmet medical needs and where the roadmap to patients is feasible and desired. Drug development, Microtubules, Tubulin code, Preclinical, Drug screening, first-in-class, and drug discovery Type: | 2 | 1 | 1 | 7 |
 | Odimma Therapeutics Empowering Personalized Immunotherapy to Treat Cancer Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy. Immunotherapy has revolutionized the treatment of many advanced cancers. Despite this amazing achievement, significant clinical benefits are still limited to 10 to 30% of patients. Odimma believes in the future of precision medicine, and leverages recent advances in the field of immuno-oncology to amplify the efficacy of current therapies, improving lives and making each patient unique. By harnessing the ability of the patient’s own immune system to specifically recognize non-self-targets displayed by the tumor, also called neoantigens, Odimma has … Type: | 10 | 3 | 8 | 7 |
 | CTIBiotech Visionary science. CTIBiotech, models for your research. CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in the pharmaceutical industry and dermato-cosmetics sectors. We also work in partnership to co-develop new models that fit a specific requirement. The CTIBiotech Biobank is accredited by French authorities and we can offer human tissues, primary cells, cell lines and tumours. We currently store around 30 000 samples, from 0-94 years and from different ethnical backgrounds. Our customers come … Type: | 19 | 2 | 15 | 22 |
 | AIXIAL GROUP Bringing reliability and expertise to clinical development Bringing reliability and expertise to clinical development. Aixial Group is a specialized clinical development partner with the commitment, expertise, and flexibility needed to deliver efficient clinical trials. Aixial Group provides the industry with an innovative and scalable offering, which includes: comprehensive clinical trial design and execution; functional service delivery; resources and platform. For more information, please visit: aixialgroup.com Service Delivery Models: • End to End Clinical Trial Services • Functional Service Provider (FSP) Model • Business Process Outsourcing (BPO) Model • Expert Consulting & Advice • Resourcing & Staffing Biometrics and Clinical Research, … Type: | 2 | 1 | 1 | 748 |
 | NBread conçoit et industrialise vos innovations... NBread-Process is an breakthrough innovative technology and a pioneering product, protected by a patent and carried by a patent and carried by a team that imagines and develops solid food foams from any raw material. Type: | 1 | 1 | 0 | 3 |
 | NissActive SAS [Automatic translation follows] From the exploitation of natural substances of Mediterranean origin to the development of innovative cosmetic active ingredients Cosmetics is a clever mix of science, research and creativity. Three key words for Nissactive, a nascent company with tenfold ambitions, specializing in the development of natural active ingredients in order to promote and enhance biodiversity. A true source of inspiration, nature is an exploitable source of wealth, making it possible to provide customers and partners with innovative cosmetic ingredients. In order to enhance local wealth, various studies are carried out using Mediterranean plants as well as agricultural by-products through … Type: | 5 | 2 | 1 | 2 |
 | Biosme Paris [Automatic translation follows] The first expert skincare offer for sensitive skin that respects the skin microbiome, certified natural and organic The whole BIOSME adventure started with a strange challenge: formulating a natural deodorant that really works! We were far from imagining what this project would reveal to us: the importance of the human microbiome, its extraordinary functioning and all that cosmetics could do to preserve it. In 2015, we patented a complex combining saccharomyces and lactobacilli ferments offering remarkable protection against body odors, the Pro-active deo complex. This complex of active ingredients gave birth to the company's first range: daydry … Type: | 1 | 0 | 1 | 2 |
SMB